• Company specialized in advanced bio-medicine development.
    Asia #1
    hair follicle research lab

    Stemore is an advanced biopharmaceutical research company
    that pursues health and happiness

  • Company specialized in advanced bio-medicine development.
    Making the insurmountable, possible

    Stemore is an advanced biopharmaceutical research company
    that pursues health and happiness

  • Company specialized in advanced bio-medicine development.
    Company that helps patients to be healthy and have a confident life

    Stemore is an advanced biopharmaceutical research company
    that pursues health and happiness

123

Stemore Developments
Provide total solution for hair loss

Stemore is developing cell and antibody treatments in response to the rising demand for hair restoration medical needs, while also conducting R&D in skin regeneration treatments to create commercially viable consumer products.

COMPANY

We will grow into a company that specializes in developing advanced biopharmaceutical products while pursuing the health and happiness of the people.

HISTORY

Footsteps of Stemore on developing hair loss treatment cells for many years

PRODUCT

Development of cell and antibody treatment for hair loss
R&D and commercialization for skin regeneration treatment

DRUGS

We consider our patient’s happiness and future.

MEWSMedia

Current issues of Stemore

Stemore receives an award from Korea Health Industry Development Institute president

Received an award certificate of KHIDI
2020.12.10
more

[Scientific Reports] Stemore published a SM-002 material research paper, under development

Hair growth promotion by necrostatin-1s
2020.10.22
more

The secret to attract more than 10 billion won in investment ‘Personalized hair loss treatment’

Interview with Jong Hyuk Sung, CEO of Stemore
2020.10.07
more

Stemore discovers new growth factors to prevent hair loss… Selected as the cover paper for an international journal

Stemore Co. research lab’s paper on hair loss has been selected as a cover paper in the September issue of ‘Cell Proliferation’
2020.09.09
more
more